Phaik‐Eng Sum

In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- <i>t</i> -Butylglycylamido Derivative of Minocycline (GAR-936)

Peter J. Petersen, N V Jacobus, Jason Weiss et al. · Antimicrobial Agents and Chemotherapy · 1999 · 410 citations · Full text

Pharmaceutical Science, Glycobiology, Ribosomal Protection +22

Efflux-Mediated Resistance to Tigecycline (GAR-936) in <i>Pseudomonas aeruginosa</i> PAO1

Charles R. Dean, M Visalli, Steven J. Projan et al. · Antimicrobial Agents and Chemotherapy · 2003 · 281 citations · Full text

Bacteriology, Antibiotic Resistance, Bacterial Pathogens +18

In Vitro and In Vivo Activities of Tigecycline (GAR-936), Daptomycin, and Comparative Antimicrobial Agents against Glycopeptide-Intermediate<i>Staphylococcus aureus</i>and Other Resistant Gram-Positive Pathogens

Peter J. Petersen, Patricia A. Bradford, Jason Weiss et al. · Antimicrobial Agents and Chemotherapy · 2002 · 168 citations · Full text

Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5

Lidia Mosyak, Katy E. Georgiadis, Tania Shane et al. · Protein Science · 2007 · 138 citations · Full text

Protein Assembly, Glycobiology, Molecular Biology +17

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines

R. T. TESTA, Peter J. Petersen, N V Jacobus et al. · Antimicrobial Agents and Chemotherapy · 1993 · 123 citations · Full text